PARK HA BIOLOGICAL TECH-A (BYAH) Fundamental Analysis & Valuation

NASDAQ:BYAH • KYG6925R1020

Current stock price

1.2 USD
+0.05 (+4.35%)
At close:
1.19 USD
-0.01 (-0.83%)
After Hours:

This BYAH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BYAH Profitability Analysis

1.1 Basic Checks

  • BYAH had negative earnings in the past year.
  • In the past year BYAH had a positive cash flow from operations.
BYAH Yearly Net Income VS EBIT VS OCF VS FCFBYAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500K 1M

1.2 Ratios

  • BYAH's Return On Assets of -331.89% is on the low side compared to the rest of the industry. BYAH is outperformed by 94.35% of its industry peers.
  • Looking at the Return On Equity, with a value of -455.43%, BYAH is doing worse than 77.42% of the companies in the same industry.
Industry RankSector Rank
ROA -331.89%
ROE -455.43%
ROIC N/A
ROA(3y)20.25%
ROA(5y)N/A
ROE(3y)81.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYAH Yearly ROA, ROE, ROICBYAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60 80 100

1.3 Margins

  • BYAH has a better Gross Margin (92.99%) than 98.39% of its industry peers.
  • BYAH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 92.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BYAH Yearly Profit, Operating, Gross MarginsBYAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BYAH Health Analysis

2.1 Basic Checks

  • BYAH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BYAH has less shares outstanding
  • There is no outstanding debt for BYAH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BYAH Yearly Shares OutstandingBYAH Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M 25M
BYAH Yearly Total Debt VS Total AssetsBYAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M

2.2 Solvency

  • BYAH has an Altman-Z score of -7.62. This is a bad value and indicates that BYAH is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -7.62, BYAH is not doing good in the industry: 88.71% of the companies in the same industry are doing better.
  • There is no outstanding debt for BYAH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -7.62
ROIC/WACCN/A
WACC8.42%
BYAH Yearly LT Debt VS Equity VS FCFBYAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 500K 1M 1.5M

2.3 Liquidity

  • BYAH has a Current Ratio of 3.68. This indicates that BYAH is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.68, BYAH belongs to the best of the industry, outperforming 91.13% of the companies in the same industry.
  • A Quick Ratio of 3.63 indicates that BYAH has no problem at all paying its short term obligations.
  • BYAH has a Quick ratio of 3.63. This is amongst the best in the industry. BYAH outperforms 95.97% of its industry peers.
Industry RankSector Rank
Current Ratio 3.68
Quick Ratio 3.63
BYAH Yearly Current Assets VS Current LiabilitesBYAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BYAH Growth Analysis

3.1 Past

  • BYAH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2189.24%.
  • BYAH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.33%.
EPS 1Y (TTM)-2189.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38931.58%
Revenue 1Y (TTM)9.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%45.29%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BYAH Yearly Revenue VS EstimatesBYAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

Find the best growth stocksShow best growing peers

1

4. BYAH Valuation Analysis

4.1 Price/Earnings Ratio

  • BYAH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYAH Price Earnings VS Forward Price EarningsBYAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • BYAH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BYAH is cheaper than 72.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.9
EV/EBITDA N/A
BYAH Per share dataBYAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BYAH Dividend Analysis

5.1 Amount

  • No dividends for BYAH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BYAH Fundamentals: All Metrics, Ratios and Statistics

PARK HA BIOLOGICAL TECH-A

NASDAQ:BYAH (3/13/2026, 8:13:01 PM)

After market: 1.19 -0.01 (-0.83%)

1.2

+0.05 (+4.35%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.52M
Revenue(TTM)3.62M
Net Income(TTM)-19.36M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.78
P/FCF 15.9
P/OCF 14.74
P/B 4.07
P/tB 4.08
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY6.29%
OCF(TTM)0.08
OCFY6.79%
SpS0.25
BVpS0.29
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -331.89%
ROE -455.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 92.99%
FCFM 30.07%
ROA(3y)20.25%
ROA(5y)N/A
ROE(3y)81.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)99.2%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 318.59%
Cap/Sales 2.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.68
Quick Ratio 3.63
Altman-Z -7.62
F-Score5
WACC8.42%
ROIC/WACCN/A
Cap/Depr(3y)176.35%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.71%
Cap/Sales(5y)N/A
Profit Quality(3y)314.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2189.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38931.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%45.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1586.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y742.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y659.29%
OCF growth 3YN/A
OCF growth 5YN/A

PARK HA BIOLOGICAL TECH-A / BYAH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PARK HA BIOLOGICAL TECH-A?

ChartMill assigns a fundamental rating of 3 / 10 to BYAH.


Can you provide the valuation status for PARK HA BIOLOGICAL TECH-A?

ChartMill assigns a valuation rating of 1 / 10 to PARK HA BIOLOGICAL TECH-A (BYAH). This can be considered as Overvalued.


Can you provide the profitability details for PARK HA BIOLOGICAL TECH-A?

PARK HA BIOLOGICAL TECH-A (BYAH) has a profitability rating of 1 / 10.